DCM

DAFNA Capital Management Portfolio holdings

AUM $440M
1-Year Est. Return 109.12%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+109.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$440M
AUM Growth
+$9.07M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
87
New
Increased
Reduced
Closed

Top Buys

1
+$10.8M
2
+$5.13M
3
+$4.36M
4
BCAX
Bicara Therapeutics
BCAX
+$2.76M
5
FULC icon
Fulcrum Therapeutics
FULC
+$1.9M

Top Sells

1
+$9.76M
2
+$7.38M
3
+$3.99M
4
RVMD icon
Revolution Medicines
RVMD
+$2.41M
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$2.25M

Sector Composition

1 Healthcare 87.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$33.5B
$56.5M 12.85%
580,678
-23,836
XBI icon
2
State Street SPDR S&P Biotech ETF
XBI
$8.54B
$40.7M 9.25%
318,505
-18,000
STXS icon
3
Stereotaxis
STXS
$194M
$25.2M 5.73%
13,680,554
DAWN
4
DELISTED
Day One Biopharmaceuticals
DAWN
$21M 4.77%
978,463
-20,700
ATRC icon
5
AtriCure
ATRC
$1.4B
$17M 3.88%
597,431
IDYA icon
6
IDEAYA Biosciences
IDYA
$2.59B
$15.9M 3.61%
476,740
-30,000
XENE icon
7
Xenon Pharmaceuticals
XENE
$5.29B
$14.6M 3.32%
250,772
-37,167
CYTK icon
8
Cytokinetics
CYTK
$10.4B
$14.3M 3.26%
217,497
-153,500
CMPS
9
Compass Pathways
CMPS
$1.76B
$13.4M 3.04%
2,418,882
+1,607,836
NKTR icon
10
Nektar Therapeutics
NKTR
$2.19B
$11.9M 2.7%
165,178
+90,180
IBB icon
11
iShares Biotechnology ETF
IBB
$8.05B
$10.5M 2.39%
62,095
-6,000
RCUS icon
12
Arcus Biosciences
RCUS
$3.19B
$9.59M 2.18%
443,829
+12,500
NBIX icon
13
Neurocrine Biosciences
NBIX
$15.9B
$9.3M 2.12%
70,615
LRMR icon
14
Larimar Therapeutics
LRMR
$362M
$9.13M 2.08%
2,029,164
+1,090,000
BCAX
15
Bicara Therapeutics
BCAX
$1.43B
$8.39M 1.91%
421,733
+160,150
AXGN icon
16
Axogen
AXGN
$2.1B
$8.28M 1.88%
249,960
-226,866
BHVN icon
17
Biohaven
BHVN
$1.66B
$7.15M 1.63%
845,735
-109,500
TNDM icon
18
Tandem Diabetes Care
TNDM
$1.18B
$6.81M 1.55%
355,208
DNLI icon
19
Denali Therapeutics
DNLI
$3.34B
$6.12M 1.39%
318,500
IPSC icon
20
Century Therapeutics
IPSC
$442M
$5.5M 1.25%
2,434,353
-359,233
DXCM icon
21
DexCom
DXCM
$28.5B
$5.42M 1.23%
86,279
-2,000
KALV icon
22
KalVista Pharmaceuticals
KALV
$1.43B
$5.38M 1.22%
267,402
-89,400
ASND icon
23
Ascendis Pharma A/S
ASND
$13.8B
$5.3M 1.21%
23,177
-5,000
MBX
24
MBX Biosciences
MBX
$1.5B
$5.24M 1.19%
175,465
+10,200
INGN icon
25
Inogen
INGN
$176M
$5.22M 1.19%
845,179
+18,108
1
2 3 4